Furthermore, fisetin disrupts the NF-κB signal transduction pathway targets (p65, IκBα, and cyclinD1) activated by EBV-LMP1, as evidenced by in vitro studies on EBV-infected NPC cells [94]. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.